|
OSBPL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.212000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.248770E-01 |
| Normal-vs-Stage2 |
1.448800E-01 |
| Normal-vs-Stage3 |
9.747600E-02 |
| Normal-vs-Stage4 |
7.064300E-02 |
| Stage1-vs-Stage2 |
6.679000E-01 |
| Stage1-vs-Stage3 |
7.095200E-01 |
| Stage1-vs-Stage4 |
5.326200E-01 |
| Stage2-vs-Stage3 |
8.905000E-01 |
| Stage2-vs-Stage4 |
9.018200E-01 |
| Stage3-vs-Stage4 |
7.630400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.608400E-02 |
| Normal-vs-AfricanAmerican |
6.722800E-01 |
| Normal-vs-Asian |
2.097600E-01 |
| Caucasian-vs-AfricanAmerican |
3.488400E-01 |
| Caucasian-vs-Asian |
7.028200E-01 |
| AfricanAmerican-vs-Asian |
5.910600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.733600E-02 |
| Normal-vs-Female |
5.773900E-02 |
| Male-vs-Female |
7.395800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.636500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.728300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.205010E-01 |
| Normal-vs-Age(81-100Yrs) |
9.441000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.095400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.106400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.326400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.613200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.503000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.693000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.109400E-01 |
| Classical-VS-Follicular |
7.839800E-04 |
| Classical-VS-Other |
6.040600E-01 |
| Classical-VS-Normal |
9.355600E-03 |
| Tall-VS-Follicular |
7.004100E-02 |
| Tall-VS-Other |
7.614400E-01 |
| Tall-VS-Normal |
1.135030E-01 |
| Follicular-VS-Other |
5.819400E-01 |
| Follicular-VS-Normal |
8.356000E-01 |
| Other-VS-Normal |
5.481800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.905400E-01 |
| Normal-vs-N1 |
6.059100E-03 |
| N0-vs-N1 |
1.033910E-02 |
|
|
